United Therapeutics extends licensing deal with Eli Lilly even as generic competition intensifies


The company is still betting on some revenue from the Eli Lilly partnership even as it faces stiff competition from generic drugmakers.

Previous COO of Mass General Hospital steps down after 30 years with parent organization
Next Hanes rolls out Champion line made with biodegradable synthetic fibers to help build sustainability rep